Cellectis SA (CLLS)

3.57 +0.07 (+2.00%) USD  |  NASDAQ  |  Feb 06, 16:00
3.74 +0.17 (+4.76%) Pre-Market: 08:08
More

Cellectis Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
EDAP TMS SA Upgrade
DBV Technologies SA Upgrade
Ascendis Pharma A/S Upgrade
Akari Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc --